Precision Therapeutics to Raise $30+ Million
July 30, 2008
Precision Therapeutics expects to close on more than $30 million in venture funding, the largest round raised in the company's 13-year existence. Investors in the round included existing firms (including Draper Triangle) as well as some new out-of-town backers. CEO Sean McDonald plans to increase his company's staff by 50% this year, and plans to use the money to hire across the board, and for continued research into the company's personalized cancer therapies.
« Landslide Summer 2008 Release Available | | Carnegie Learning Sees New Act as Beneficial to Higher Education »
